The current situation of health services for hydatidiform mole in Cambodia.

Autor: Yamamoto E; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Kanal K; Cambodian Society of Gynecology and Obstetrics, Phnom Penh, Cambodia., Soeung SC; Cambodian Society of Gynecology and Obstetrics, Phnom Penh, Cambodia., Fujita N; Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan., Krang S; Communicable Disease Control Department, Ministry of Health, Phnom Penh, Cambodia., Long-Hay P; Communicable Disease Control Department, Ministry of Health, Phnom Penh, Cambodia., Nishino K; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Niimi K; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Hamajima N; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Jazyk: angličtina
Zdroj: The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2021 Oct; Vol. 47 (10), pp. 3652-3660. Date of Electronic Publication: 2021 Aug 03.
DOI: 10.1111/jog.14955
Abstrakt: Aim: Management of hydatidiform mole is important to reduce the mortality and morbidity of choriocarcinoma. This study aims to understand the existing health services for hydatidiform mole and to estimate the incidence of gestational trophoblastic disease (GTD) in Cambodia.
Methods: A questionnaire was used to collect information on the existing health services for pregnancy and hydatidiform mole at health facilities from attendants of the 16th Annual Conference of the Cambodian Society of Gynecology and Obstetrics in 2017. The incidence of GTD in 2014-2017 was estimated using Health Information System data.
Results: A total of 126 attendants, who were from all provinces except three provinces, answered the questionnaire. The work places were national hospitals (n = 29), provincial hospitals (n = 42), district hospitals (n = 20), health centers (n = 6), and others (n = 29). The answers of participants from the public sector suggested the following: Ultrasonography is available at all hospitals but not health centers; Human chorionic gonadotropin (hCG) measurement is only available at national hospitals; Treatment of hydatidiform mole is performed at national hospitals and provincial hospitals; and Treatment of gestational trophoblastic neoplasia (GTN) is provided at national hospitals. The incidence of hydatidiform mole and GTN at health facilities in the public sector in 2014-2017 was 0.95 per 1000 deliveries and 6.58 per 100 000 deliveries, respectively.
Conclusions: The results suggest that provincial hospitals are important to detect suspected invasive mole and refer to national hospitals for diagnosis and treatment. Further studies on the management of GTD and development of the guidelines of GTD are needed.
(© 2021 Japan Society of Obstetrics and Gynecology.)
Databáze: MEDLINE
Externí odkaz: